| ||||||||||||||
|
|
|||||||||||||


*Department of Anesthesiology, Duke University Medical Center;
Center for Health Policy, Law, and Management, Duke University; and
Fuqua School of Business, Duke University, Durham, North Carolina
Address correspondence and reprint requests to T. J. Gan, Department of Anesthesiology, Duke University Medical Center, Box 3094, Durham, NC 27710. Address e-mail to gan00001{at}mc.duke.edu
Postoperative nausea and vomiting (PONV) are unpleasant experiences. However, there is no drug that is completely effective in preventing PONV. Whereas cost effectiveness analyses rely on specific health outcomes (e.g., years of life saved), cost-benefit analyses assess the cost and benefit of medical therapy in terms of dollars. We hypothesized that patients were willing to pay for a hypothetical new drug that would eliminate PONV. Eighty elective day surgical patients using general anesthesia participated in the study. After their recovery in the postanesthetic care unit, they were asked to complete an interactive computer questionnaire on demographics, the value of avoiding PONV, and their willingness to pay for an antiemetic. Patients were willing to pay US$56 (US$26US$97; median, 25%75%) for an antiemetic that would completely prevent PONV. Patients who developed nausea (n = 21; 26%) and vomiting (n = 9; 11%) were willing to pay US$73 (US$44US$110) and $100 (US$61US$200; median, 25%75%), respectively (P < 0.05). Seventy-six percent of patients considered avoiding postoperative nausea and 78% of patients considered avoiding vomiting as important (
50 mm on a 0100-mm visual analog scale). Nausea or vomiting in the postanesthetic care unit, greater patient income, previous history of PONV, more importance placed on avoiding nausea and vomiting, increasing age, and being married are independent covariates that increase the willingness to pay estimates. Patients associated a value with the avoidance of PONV and were willing to pay between US$56 and US$100 for a completely effective antiemetic.
Implications: We have established a cost-benefit analysis for an antiemetic therapy. Patients highly value avoiding postoperative nausea and vomiting. The amount they are willing to pay for a totally effective antiemetic is US$61$US113..
This article has been cited by other articles:
![]() |
P. Diemunsch, G. P. Joshi, and J.-F. Brichant Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting Br. J. Anaesth., July 1, 2009; 103(1): 7 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Rowbotham Neurokinin-1 antagonists: a step change in prevention of postoperative nausea and vomiting? Br. J. Anaesth., July 1, 2009; 103(1): 5 - 6. [Full Text] [PDF] |
||||
![]() |
T. J. Gan, A. C. Sinha, A. L. Kovac, R. K. Jones, S. A. Cohen, J. P. Battikha, J. S. Deutsch, J. V. Pergolizzi Jr, the TDS Study Group, and P. S. A. Glass A Randomized, Double-Blind, Multicenter Trial Comparing Transdermal Scopolamine Plus Ondansetron to Ondansetron Alone for the Prevention of Postoperative Nausea and Vomiting in the Outpatient Setting Anesth. Analg., May 1, 2009; 108(5): 1498 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Wender Do current antiemetic practices result in positive patient outcomes? Results of a new study Am. J. Health Syst. Pharm., January 1, 2009; 66(1_Supplement_1): S3 - S10. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gan, T. A. Meyer, C. C. Apfel, F. Chung, P. J. Davis, A. S. Habib, V. D. Hooper, A. L. Kovac, P. Kranke, P. Myles, et al. Society for Ambulatory Anesthesia Guidelines for the Management of Postoperative Nausea and Vomiting Anesth. Analg., December 1, 2007; 105(6): 1615 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Bolton, P. S. Myles, J. B. Carlin, and T. Nolan Randomized, double-blind study comparing the efficacy of moderate-dose metoclopramide and ondansetron for the prophylactic control of postoperative vomiting in children after tonsillectomy Br. J. Anaesth., November 1, 2007; 99(5): 699 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cucchiaro, S. N. Adzick, J. B. Rose, L. Maxwell, and M. Watcha A comparison of epidural bupivacaine-fentanyl and bupivacaine-clonidine in children undergoing the Nuss procedure. Anesth. Analg., August 1, 2006; 103(2): 322 - 7, table of contents. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gan Risk factors for postoperative nausea and vomiting. Anesth. Analg., June 1, 2006; 102(6): 1884 - 1898. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cucchiaro, J. T. Farrar, J. W. Guite, and Y. Li What Postoperative Outcomes Matter to Pediatric Patients? Anesth. Analg., May 1, 2006; 102(5): 1376 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Carvalho, S. E. Cohen, S. S. Lipman, A. Fuller, A. D. Mathusamy, and A. Macario Patient Preferences for Anesthesia Outcomes Associated with Cesarean Delivery Anesth. Analg., October 1, 2005; 101(4): 1182 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Burlacu, D. Healy, D. J. Buggy, C. Twomey, D. Veerasingam, A. Tierney, and D. C. Moriarty Continuous Gastric Decompression for Postoperative Nausea and Vomiting After Coronary Revascularization Surgery Anesth. Analg., February 1, 2005; 100(2): 321 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Meyer, C. R. Roberson, M. H. Rajab, J. Davis, and C. H. McLeskey Dolasetron Versus Ondansetron for the Treatment of Postoperative Nausea and Vomiting Anesth. Analg., February 1, 2005; 100(2): 373 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lee, T. Gin, A. S. C. Lau, and F. F. Ng A Comparison of Patients' and Health Care Professionals' Preferences for Symptoms During Immediate Postoperative Recovery and the Management of Postoperative Nausea and Vomiting Anesth. Analg., January 1, 2005; 100(1): 87 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. White Prevention of Postoperative Nausea and Vomiting -- A Multimodal Solution to a Persistent Problem N. Engl. J. Med., June 10, 2004; 350(24): 2511 - 2512. [Full Text] [PDF] |
||||
![]() |
T. J. Gan, G. P. Joshi, E. Viscusi, R. Y. Cheung, W. Dodge, J. G. Fort, and C. Chen Preoperative Parenteral Parecoxib and Follow-Up Oral Valdecoxib Reduce Length of Stay and Improve Quality of Patient Recovery After Laparoscopic Cholecystectomy Surgery Anesth. Analg., June 1, 2004; 98(6): 1665 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gan, D. A. Lubarsky, E. M. Flood, T. Thanh, J. Mauskopf, T. Mayne, and C. Chen Patient preferences for acute pain treatment{dagger} Br. J. Anaesth., May 1, 2004; 92(5): 681 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R Tramer Treatment of postoperative nausea and vomiting BMJ, October 4, 2003; 327(7418): 762 - 763. [Full Text] [PDF] |
||||
![]() |
F. J. Pueyo, L. Lopez-Olaondo, M. J. Sanchez-Ledesma, A. Ortega, and F. Carrascosa Cost-effectiveness of three combinations of antiemetics in the prevention of postoperative nausea and vomiting Br. J. Anaesth., October 1, 2003; 91(4): 589 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gan, T. Meyer, C. C. Apfel, F. Chung, P. J. Davis, S. Eubanks, A. Kovac, B. K. Philip, D. I. Sessler, J. Temo, et al. Consensus Guidelines for Managing Postoperative Nausea and Vomiting Anesth. Analg., July 1, 2003; 97(1): 62 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Orkin Patient preferences for immediate postoperative recovery Br. J. Anaesth., April 1, 2003; 90(4): 526 - 527. [Full Text] [PDF] |
||||
![]() |
E. W. Moretti, K. M. Robertson, H. El-Moalem, and T. J. Gan Intraoperative Colloid Administration Reduces Postoperative Nausea and Vomiting and Improves Postoperative Outcomes Compared with Crystalloid Administration Anesth. Analg., February 1, 2003; 96(2): 611 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Erb, J. M. Hall, R. J. Ing, R. J. Kanter, F. H. Kern, S. R. Schulman, and T. J. Gan Postoperative Nausea and Vomiting in Children and Adolescents Undergoing Radiofrequency Catheter Ablation: A Randomized Comparison of Propofol- and Isoflurane-Based Anesthetics Anesth. Analg., December 1, 2002; 95(6): 1577 - 1581. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. J. Eberhart, A. M. Morin, H. Wulf, and G. Geldner Patient preferences for immediate postoperative recovery Br. J. Anaesth., November 1, 2002; 89(5): 760 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Eltzschig, T. H. Schroeder, B. J. Eissler, T. W. Felbinger, R. Vonthein, R. Ehlers, and H. Guggenberger The Effect of Remifentanil or Fentanyl on Postoperative Vomiting and Pain in Children Undergoing Strabismus Surgery Anesth. Analg., May 1, 2002; 94(5): 1173 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suresh, S. L. Barcelona, N. M. Young, I. Seligman, C. L. Heffner, and C. J. Cote Postoperative Pain Relief in Children Undergoing Tympanomastoid Surgery: Is a Regional Block Better than Opioids? Anesth. Analg., April 1, 2002; 94(4): 859 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gan Postoperative Nausea and Vomiting--Can It Be Eliminated? JAMA, March 13, 2002; 287(10): 1233 - 1236. [Full Text] [PDF] |
||||
![]() |
S. A. Strassels, C. Chen, and D. B. Carr Postoperative Analgesia: Economics, Resource Use, and Patient Satisfaction in an Urban Teaching Hospital Anesth. Analg., January 1, 2002; 94(1): 130 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hubler, R. J. Litz, D. Michael Albrecht, P. F. White, and M. Coloma Esmolol is Not an Alternative to Remifentanil for Fast-Track Outpatient Gynecologic Laparoscopic Surgery Response Anesth. Analg., July 1, 2001; 93(1): 241 - 242. [Full Text] [PDF] |
||||
|